Clinical trial
A Study in Korea of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis…
NCT00393484 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00393484 |
|---|---|
| Title | A Study in Korea of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B Infection |
| Official title | A Phase IV Study of the Antiviral Activity and Safety of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B Infection Who Are Negative for Hepatitis B e Antigen in Korea |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis B |
| Intervention type | Drug |
| Interventions | Entecavir, Lamivudine Placebo, Lamivudine, Entecavir Placebo |
| Enrollment | 122 |
| Start date | Feb 1, 2007 |
| Primary completion | Jan 1, 2009 |
| Completion | Sep 1, 2013 |
| First posted | Oct 27, 2006 |
| Last update posted | Nov 26, 2014 |
| Countries | South Korea |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: